tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geoffrey Porges, 190 are a BUY (66.2%), 95 are a HOLD (33.1%), 2 are a SELL (0.7%).
Analyst Geoffrey Porges, currently employed at LEERINK, carries an average stock price target met ratio of 61.41% that have a potential upside of 27.85% achieved within 384 days. Previously, Geoffrey Porges worked at BERNSTEIN.
Geoffrey Porges’s has documented 592 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Basic Materials, Consumer Defensive sectors.
Most recent stock forecast was given on RCUS, Arcus Biosciences at 02-Mar-2026.
Analyst best performing recommendations are on DOVA (DOVA PHARMACEUTICALS).
The best stock recommendation documented was for EPZM (EPIZYME) at 6/19/2020. The price target of $16 was fulfilled within 7 days with a profit of $2.84 (15.07%) receiving and performance score of 21.53.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Nov-2020
$273
$19.65 (7.76%)
$262
15 days ago
(23-Jun-2026)
14/16 (87.5%)
$38.24 (16.29%)
409
Buy Since 12-Sep-2025
$298
$44.65 (17.62%)
$298
15 days ago
(23-Jun-2026)
2/7 (28.57%)
$63.24 (26.94%)
35
Buy Since 23-Jan-2023
$235
$-18.35 (-7.24%)
$236
1 months 23 days ago
(15-May-2026)
8/8 (100%)
$24.61 (11.70%)
142
Buy Since 06-Feb-2020
$249
$-4.35 (-1.72%)
$249
2 months 7 days ago
(01-May-2026)
35/35 (100%)
$42.4 (20.52%)
446
Buy Since 24-Jan-2022
$278
$24.65 (9.73%)
$270
2 months 8 days ago
(30-Apr-2026)
21/24 (87.5%)
$66.68 (31.55%)
515
Which stock is Geoffrey Porges is most bullish on?
What Year was the first public recommendation made by Geoffrey Porges?
